Related Experiment Video
Updated: Jul 8, 2026

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Atherosclerosis-underlying inflammatory mechanisms and clinical implications
Sanjay Patel1, David S Celermajer, Shisan Bao
1Department of Cardiology, Royal Prince Alfred Hospital, Australia.
The International Journal of Biochemistry & Cell Biology
|January 22, 2008
Summary
Inflammation drives atherosclerosis, with leukocyte infiltration marking unstable plaques. This review explores the pro- and anti-inflammatory roles and clinical impacts of inflammation in atherosclerosis.
Area of Science:
- Cardiovascular Science
- Immunology
- Pathology
Background:
- Inflammation is crucial in atherosclerosis development and progression.
- Unstable atherosclerotic plaques show increased leukocyte infiltration compared to stable ones.
- T cell responses, cytokines, and chemokines are key inflammatory mediators.
Purpose of the Study:
- To review the pro-inflammatory processes in atherosclerosis.
- To review the anti-inflammatory processes in atherosclerosis.
- To discuss the clinical implications of these inflammatory processes.
Main Methods:
- Literature review of pro- and anti-inflammatory mechanisms in atherosclerosis.
- Analysis of the role of leukocyte infiltration and T cell responses.
- Examination of clinical implications and current management strategies.
Main Results:
- Atherosclerotic plaque destabilization is linked to heightened inflammation and leukocyte infiltration.
- T cell-mediated immune responses significantly contribute to the inflammatory milieu.
- Emerging anti-inflammatory markers offer potential therapeutic insights.
Conclusions:
- Understanding inflammation's dual role is vital for managing atherosclerosis.
- Targeting inflammatory pathways presents therapeutic opportunities.
- Further research into anti-inflammatory markers is warranted for clinical application.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation
Overview
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...